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Abstract
Human pancreatic islets engrafted into immunodeficient mice serve as an important 
model for in vivo human diabetes studies. Following engraftment, islet function can 
be monitored in vivo by measuring circulating glucose and human insulin; how-
ever, it will be important to recover viable cells for more complex graft analyses. 
Moreover, RNA analyses of dissected grafts have not distinguished which hormone-
specific cell types contribute to gene expression. We developed a method for re-
covering live cells suitable for fluorescence-activated cell sorting from human islets 
engrafted in mice. Although yields of recovered islet cells were relatively low, the 
ratios of bulk-sorted β, α, and δ cells and their respective hormone-specific RNA-Seq 
transcriptomes are comparable pretransplant and posttransplant, suggesting that the 
cellular characteristics of islet grafts posttransplant closely mirror the original donor 
islets. Single-cell RNA-Seq transcriptome analysis confirms the presence of appro-
priate β, α, and δ cell subsets. In addition, ex vivo perifusion of recovered human islet 
grafts demonstrated glucose-stimulated insulin secretion. Viable cells suitable for 
patch-clamp analysis were recovered from transplanted human embryonic stem cell-
derived β cells. Together, our functional and hormone-specific transcriptome analy-
ses document the broad applicability of this system for longitudinal examination of 
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1 |  INTRODUCTION
Pancreatic islets are the exclusive source of insulin (INS), gluca-
gon (GCG), and somatostatin (SST) hormones that are produced 
by β, α, and δ cells, respectively. The growth and differentiation 
of islet cells and their respective hormone secretion must be rig-
orously regulated to maintain glucose homeostasis. Many ele-
gant studies report transcriptome analyses of antibody-sorted or 
single-cell data derived from isolated human islets obtained from 
pancreatic organ donors (reviewed in 1). Although such data are 
invaluable, only “snapshot” information is provided from indi-
viduals with inherently variable genetics and lifestyles. Thus, 
the development of immunodeficient mice greatly enhanced 
human islet studies by permitting in vivo study of transplanted 
islets from individual donors under well-controlled experimen-
tal conditions.2-9 RNA-Seq and other gene expression analyses 
of bulk-dissected islet graft tissue have further refined the study 
of human islets in vivo.10 The recovery of sufficient live hor-
mone-specific cells from the graft for single-cell transcriptome 
and functional analysis would facilitate the expansion of in vivo 
islet studies, yet no successful attempts have been reported.
We developed a new method to recover live single cells 
from long-term human islet grafts transplanted under the kid-
ney capsule of immunodeficient mice. To validate that the 
posttransplant islet cells were representative of the pretrans-
plant primary islets from the individual donor, transplants 
were performed using normoglycemic, experimentally un-
manipulated mice. Extensive analyses of the pre and post-
transplant cells confirmed that the recovered human islet cells 
retained their hormone-specific phenotype, gene expression, 
and function posttransplant. Although our focus was on pan-
creatic islets from individual organ donors, we also verified 
that our islet graft recovery method allowed efficient recov-
ery of live cells following long-term transplantation of human 
embryonic stem cell (SC)-derived β cells. Taken together, 
these data suggest that this model system may be useful for 
interrogating the response of transplanted human islets or 
SC-β cells to various developmental, metabolic, or therapeu-
tic regimens in vivo. In vivo assessment of the effects of such 
manipulations on transplanted human islets at the individual 
cell level, in turn, should lead to more focused clinical studies 
for the treatment and/or prevention of diabetes.
2 |  MATERIALS AND METHODS
2.1 | Human islet procurement, SC-beta cell 
generation, and pretransplant analysis
Human islets were obtained from the NIH Integrated Islet 
Distribution Program or Prodo Laboratories Inc (Aliso Viejo, 
CA, USA) (Table 1). To compare the pretransplant human islet 
cellular composition (which can vary widely) and gene expres-
sion to that measured posttransplant, we studied an aliquot of 
4000 to 7000 islet equivalents (IEQs) from each donor pretrans-
plant. The human SC-β cells were generated as previously de-
scribed.11 The islets were stained with antibodies to INS, GCG, 
and SST and then separated by fluorescence-activated cell sort-
ing (FACS) into β, α, and δ-cells, respectively, using method-
ology developed in our laboratory.12 The sorted endocrine cell 
populations and the subpopulation of triple-negative cells were 
pelleted and Proteinase K digested using the Digestion Buffer 
from the RecoverAll Total Nucleic Acid Isolation kit (Ambion, 
Austin, TX, USA). Following protease digestion, samples were 
diluted in an equal volume of nuclease-free water and nucleic 
acids were purified using 1.9 volumes of Agencourt RNAClean 
XP beads (Beckman Coulter, Brea, CA, USA). Following elution 
with nuclease-free water, the purified nucleic acids were treated 
with TURBO DNase (Ambion) and purified using 1.9 volumes 
of Agencourt RNAClean XP beads. RNA eluted in water was 
quantified and analyzed for RNA Integrity Number (RIN) using 
an Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, 
CA, USA), and stored at −80°C until further processing.
2.2 | Mice and islet and SC-β 
transplantation
Twelve- to 16-week-old NOD-Prkdcscid IL2rgtm1wjl (NSG) 
mice of both sexes were obtained from The Jackson 
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Laboratory. Mice were housed in a specific pathogen-free 
facility. All procedures were approved by the Institutional 
Animal Care and Use Committee (IACUC) of the University 
of Massachusetts Medical School. Islet transplants and SC-β 
cell transplants were performed as previously described.3,8,11 
Briefly, mice were anesthetized and the kidney was exter-
nalized through an incision through the skin and abdominal 
wall; ~4000 IEQs or 5 million SC-β cells (Douglas Melton 
lab, Harvard University, Cambridge, MA, USA) were in-
jected into the renal subcapsular space using a 23G winged 
infusion set (Terumo Medical Corporation, Somerset, NJ, 
USA). The kidney was reinserted into the abdomen and the 
incision was closed.
2.3 | In vivo glucose stimulation
To confirm human islet function in vivo, at 2 to 3 weeks post-
engraftment, mice were given an intraperitoneal injection of 
glucose (2 g/kg body weight). Blood sample was collected 
from the tail vein 15 minutes post-injection into heparinized 
tubes; plasma was collected and stored at −80°C until analy-
sis. Human plasma INS levels were determined using a hu-
man-specific enzyme-linked immunosorbent assay (ELISA, 
ALPCO, Salem, NH, USA); unengrafted NSG mouse plasma 
was used as a negative control.
2.4 | Islet and SC-β cell graft recovery and 
dissociation
At 4 to 5 weeks post-engraftment, mice were deeply anesthe-
tized and the engrafted kidney was exposed through a mid-
line incision. The kidney was injected with 1 mL collagenase 
(Sigma, St. Louis, MO, USA, C-0130, 0.125 mg/mL) in RPMI 
1640/2% horse serum (Gibco, Grand Island, NY, USA), then 
removed and the animal was quickly euthanized according 
to the approved IACUC protocol. The graft was located and 
the kidney was bisected into two hemispheres. The capsule 
containing the islet graft was peeled from the kidney hemi-
sphere and placed into a large volume of RPMI 1640 con-
taining 50% horse serum and the sample was placed on ice. 
Kidney capsules with attached grafts were first washed with 
Hank's balanced salt solution (HBSS, Mediatech, Manassas, 
VA, USA), then with 10 mM ethylenediaminetetraacetic acid 
(EDTA) in phosphate-buffered saline (PBS, Mediatech). The 
capsules were placed in 1 mL of pre-warmed PBS to 37°C, 
and 0.5  mL of pre-warmed TrypLE Express (Gibco) was 
added. Capsules and attached grafts were gently passaged 
through a blunt 16G needle 10 times per minute for 10 min-
utes to release the islet cells, then 5 mL of 2% bovine serum 
albumin (BSA) in PBS was added to quench the enzyme. 
Following the addition of 5 mL PBS, capsules were removed 
and the dissociated islet cells were washed with PBS.
2.5 | Immunohistochemistry
To interrogate the different stages of human islet cell recov-
ery, selected islet graft-bearing kidneys, kidney capsules 
with attached grafts, and post-dissociation kidney capsules 
were separately obtained from individual mice and fixed 
in 10% neutral-buffered formalin and embedded in paraf-
fin. Paraffin sections were stained with guinea pig anti-INS 
(Dako, Carpinteria, CA, USA), mouse anti-GCG (Abcam, 
Cambridge, MA, USA), DAPI (4′6-diamidino-2-phenylin-
dole, Sigma), and Alexa Fluor-labeled secondary antibod-
ies (Molecular Probes, Eugene, OR, USA). Images were 
T A B L E  1  Demographic characteristics of human islet donors
  Donor 15275 Donor 15306 Donor 16083 Donor 15071
RRID SAMN08773851     SAMN08774475
Age, years 38 41 37 22
Gender M F F M
Ethnicity White Hispanic Hispanic/ Hawaiian/White African-American
Body weight, kg 86.6 70.3 72.6 110.2
Height, in 66 68 67 72
BMI, kg/m2 30.8 23.6 25.1 33
HbA1c, % 5.5 5.6 5.5 5.4
Confirmed type 2 diabetic donor No No No No
Time in culture (hours)a 22 nr nr 84
Transplanted IEQs/mouse 3800 4000 4000 4000
Sequencing analysis Bulk RNA-Seq Bulk RNA-Seq Bulk RNA-Seq Single-cell RNA-Seq
Abbreviations: BMI, body mass index; nr, not recorded; RRID, Research Resource Identifier, when available.
aRefers to the amount of time that the human islets were cultured following isolation until shipment to our laboratory. 
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acquired with a Nikon Eclipse Ti series microscope and ana-
lyzed with Nikon Elements image analysis software.
2.6 | Islet cell staining and FACS sorting
Following PBS washes, the dissociated islet graft cell pools 
were subjected to live/dead staining with Zombie Violet 
(BioLegend, San Diego, CA, USA). After a PBS wash, cells 
were fixed with 4% paraformaldehyde for 5 minutes on ice. 
Saponin was then added to a final concentration of 0.1% and 
the tube was rotated end over end for 25 minutes at 4°C. Cells 
were washed in PBS, then stained with Zenon Alexa 488 la-
beled mouse anti-somatostatin (clone 7G5, Thermo Fisher 
Scientific, Waltham, MA, USA), Zenon Alexa 568 (Molecular 
Probes) labeled mouse anti-glucagon (G2654, Sigma), and rab-
bit anti-insulin Alexa 647 (9008, Cell Signaling Technology, 
Danvers, MA, USA). Stained cells were sorted using a BD 
Biosciences FACS Aria II (UMass Medical School Flow Core 
Laboratory) and collected in PBS containing 0.5% BSA and 
RNasin (Promega, Madison, WI, USA).
2.7 | RNA isolation and quantitation
The sorted endocrine cell populations and the population 
of triple-negative cells were pelleted and digested using 
the Ambion RecoverAll Total Nucleic Acid Isolation 
Digestion Buffer and Proteinase K. Following nucleic acid 
purification and DNase treatment, RNA was purified as de-
scribed above.
2.8 | Library construction and sequencing
Libraries of bulk-sorted β and α cells (pre and posttransplant) 
were constructed using the SMARTer Stranded Total RNA-
Seq Kit—Pico Input Mammalian (Takara Bio USA, Mountain 
View, CA, USA) following the manufacturer's instructions. 
Islet grafts from a single human donor were dissociated, fixed, 
and stained for islet hormones as described above, then FAC-
sorted into a 384-well plate (one cell per well) for single-cell 
RNA-Seq using SCRB-Seq.13  All libraries were sequenced 
using an Illumina (San Diego, CA, USA) NextSeq 500.
2.9 | Bioinformatics analyses
Following FASTQ file generation in BaseSpace (Illumina), 
sequence files from bulk cell libraries were processed as 
described previously,14 except that expected counts were 
filtered to include only genes with  >  10 counts in at least 
three samples prior to submission to DESeq2 for differen-
tial gene expression analysis. Genes with at least a twofold 
change in expression and adjusted P values of  <  .01 were 
considered differentially expressed between pretransplant 
and posttransplant groups. All bulk and single-cell RNA-Seq 
data are available in the Gene Expression Omnibus reposi-
tory (DataSet Identifier GSE13 8748).
2.10 | Electrophysiology
Whole-cell currents from dissociated β cells were re-
corded at room temperature (20-24°C) with an Axon 200B 
patch-clamp amplifier. Cells were exposed to dithizone for 
2-5 minutes to identify β cells within the field of view and 
then washed off before establishing the whole-cell configu-
ration. Currents were acquired using Signal 2.15 software 
(Cambridge Electronic Design; CED, Cambridge, UK) and 
stored for later analysis. Currents were elicited by stepping 
from −80 mV to 0 mV for 75 msec every 5 seconds. Currents 
were sampled at 5 kHz, filtered at 1 kHz and digitized at 5 
times the filter cut-off frequency of the 4-pole Bessel filter of 
the amplifier using a micro1401 interface (CED). Linear leak 
and capacitive currents were subtracted from all traces.
Electrodes were pulled from borosilicate glass capillary 
tubes (Drummond Scientific Company, Broomall, PA, USA) 
and each electrode was fire-polished to ~1  μm to give the 
pipette a resistance of 2-3 MΩ. The pipette solution consisted 
of (in mM): 125 Cs-aspartate, 10 HEPES (4-[2-hydroxyeth-
yl]-1-piperazineethanesulfonic acid), 10 EGTA, 5 MgCl2, and 
4 ATP brought to pH 7.50 with CsOH. High-resistance seals 
were established in Ca2+ Tyrode's solution that consisted of 
(in mM): 5 CaCl2, 145 NaCl, 5.4 KCl, 10 HEPES, 3 glucose, 
and 10 tetraethylammonium (TEA), brought to pH 7.50 with 
TEA. Once a seal was established and the membrane rup-
tured, the Tyrode's solution was exchanged for an external 
bath solution (in mM): 125 NMG-aspartate, 20 Ba-acetate, 
10 HEPES, 3 glucose, and 10 TEA, brought to pH 7.50 with 
TEA. The L-type Ca2+ channel agonist FPL 64176 (FPL) was 
included in the bath solution to enhance the current ampli-
tude and elicit a slow, long-lasting L-channel tail current.15 A 
10 mM FPL stock solution was prepared in 100% ethanol and 
stored at −20°C. The FPL stock was diluted daily to a final 
concentration of 2  μM with external solution. All reagents 
used for acquiring whole-cell currents were purchased from 
Sigma-Aldrich unless otherwise noted.
3 |  RESULTS
3.1 | Human islet grafts are functional in 
vivo and following graft recovery
An overview of the study design is shown in Figure 1. 
For transplant studies, human pancreatic islets from four 
nondiabetic donors were used (Table 1); islets from each 
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donor constituted an independent study. A small aliquot 
of human islets was stained with dithizone to verify INS 
production (Figure 2A) and, for the bulk transcriptome 
experiments, 4000-7000 IEQs were reserved for staining 
and FACS to compare the pretransplant (ie, pre-engraft-
ment) human islet cellular composition and gene expres-
sion to that measured in recovered islets posttransplant 
(ie, post-engraftment). Remaining islets were transplanted 
into the renal subcapsular space of euglycemic immunode-
ficient NSG mice (n = 4-8 mice for each islet donor, ~4000 
IEQs per mouse).
At 2  weeks posttransplant, a representative engrafted 
mouse was euthanized to validate that adequate vascular-
ization of the islet graft had occurred prior to testing for 
F I G U R E  1  Overview. Human islet cells were transplanted into mice, recovered, and assessed as shown
F I G U R E  2  Islet graft transplant and functional assays. A, Human islets prior to transplant; stained with dithizone (inset). B, Islet graft 
following transplant under the kidney capsule (left); higher magnification shows vascularization of the graft (right). C, Human plasma INS 
recovered from mice challenged with glucose (2 g/kg body weight). D, Islet grafts (n = 2) were excised from the kidney, and GSIS was performed 
by perifusion. Insulin levels are shown in response to 20 mM glucose (gray bar) and KCl (yellow bar) as a percentage of total INS; the levels 
from each of two grafts are shown as a point with the average as a dashed line. E, INS (green) and GCG (red) staining of the kidney capsule and 
associated islet graft pre- (left) and post- (right) graft recovery, demonstrating successful removal of the graft from the kidney capsule 
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islet function (Figure 2B). At 2-3  weeks posttransplant, 
mice were challenged with intraperitoneal glucose (2 mg/
kg body weight). Plasma collected 15 minutes post-stim-
ulation showed robust human INS secretion (Figure 2C), 
confirming that the human islet grafts were functional in 
vivo.
At 4-5 weeks posttransplantation, the animals were anes-
thetized and the graft-bearing kidneys were recovered and bi-
sected to retain the graft-containing hemisphere. To validate 
the function of the islet grafts posttransplant, glucose-stimu-
lated insulin secretion (GSIS) was measured by perifusion of 
representative islet grafts from individual donors in indepen-
dent studies. The kidney capsule was peeled away from the 
kidney proper and, together with its attached graft, placed in 
a chamber of a Biorep Technologies perifusion machine and 
perifused as described.16 Briefly, the grafts were first main-
tained in basal (5.6  mM) glucose, then GSIS was demon-
strated following treatment with 16.8 mM glucose; sufficient 
KCl (20 mM) to produce islet depolarization resulted in a fur-
ther release of INS (Figure 2D). Together, these data indicate 
that the recovered posttransplant islet grafts were functional 
and glucose-responsive, albeit with glucose-stimulated insu-
lin responses a bit lower than typically observed using freshly 
isolated human islets. The remaining graft-containing peeled 
kidney capsules were processed for islet cell recovery (see 
MATERIALS AND METHODS). Release of the capsule 
and attached graft by the initial collagenase treatment had no 
obvious effect on the engrafted islets, as INS and GCG im-
munostaining was robust (Figure 2E, left panel). Islets were 
mechanically and chemically dissociated from the kidney 
capsule into a single-cell suspension (see MATERIALS AND 
METHODS). Immunostaining of the kidney capsule follow-
ing this step revealed no detectable INS and GCG staining, 
indicating efficient recovery of the transplanted human islets 
(Figure 2E, right panel).
3.2 | Ratios of β and α cells for each islet 
donor are similar pre and posttransplant by 
flow cytometry assessment
All dissociated cells from the recovered posttransplant islet 
grafts from a single donor were pooled, incubated with live/
dead stain, fixed, and permeabilized. Immunostaining was 
performed with INS, GCG, and SST antibodies directly con-
jugated to appropriate fluorochromes. Islet cells were sorted 
based on immunostaining and the proportions of stained en-
docrine cells were compared with those obtained pretrans-
plant (Figure 3A). We observed three major cell populations 
identified by their hormone expression as β (INS-positive), α 
(GCG-positive), and δ (SST-positive) cells, as well as a fourth 
population of triple-negative cells. As we and others have re-
ported previously,12 the relative β and α cell proportions vary 
considerably from donor to donor (Figure 3B). However, 
within each individual human donor islet prep, the percent-
ages of β and α cells recovered from the islet grafts were es-
sentially unchanged from their pretransplant levels, although 
we observed an apparent ~50% loss of SST-expressing δ 
cells in the posttransplant recovered cells (Figure 3B).
3.3 | The β- and α-cell transcriptomes 
for each islet donor are correlative pre and 
posttransplant
For each independent islet transplant study, the sorted cell 
populations from both the recovered posttransplant human 
islet grafts from each donor and primary islets from the same 
donor acquired pretransplant were processed for RNA iso-
lation. RNA-Seq libraries from sorted β and α cells (from 
islets from donors 15275, 15306, and 16083, see Table 1) 
pre and posttransplant were constructed and sequenced to 
F I G U R E  3  Hormone-specific islet cell recovery from human islet engrafted mice. A, Dissociated live cells from pretransplant islets and 
recovered human islet grafts were fixed, stained, and sorted based on their hormone expression; shown is a representative FACS sort of cells 
recovered from islet grafts from a single donor. B, The percentages of hormone-specific cells were similar for each individual donor pretransplant 
and posttransplant. Abbreviations: GCG, glucagon; INS, insulin; Neg, triple negative for INS, GCG, and SST; pre, pretransplant; post, 
posttransplant; SST, somatostatin 
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obtain an unbiased comparison of gene expression patterns 
between individual donor islets pre and posttransplant. Of 
the genes passing our filter (16 622 in β cells; 16 439 in α 
cells), 93.1% of β-cell transcripts and 88.7% of α-cell tran-
scripts were expressed at similar levels, that is, < twofold 
difference, pre and posttransplantation. Correlations for pre 
and posttransplantation transcript abundance of the 200 most 
abundant genes (as an average of the three islet donors) are 
shown in Figure 4 for β and α cells. INS and MALAT1 (me-
tastasis-associated lung adenocarcinoma transcript 1) are the 
most abundant transcripts both pre and posttransplant in β 
cells (Figure 4, left); and, in the α-cell populations, GCG 
and MALAT1 are the most abundant transcripts pre and post-
transplant (Figure 4, right). MALAT1 is a long non-coding 
RNA (lncRNA) highly expressed in purified human β and 
α cells.17 Intriguingly, MALAT1 resides within an active en-
hancer cluster containing multiple binding sites for islet tran-
scription factors, suggesting a critical role in gene regulation 
of human islets.18
Transcripts which are notably differentially expressed 
between pre and posttransplant include several which are 
likely due to contaminating exocrine pancreas material. For 
example, in β cell populations, PRSS1, which encodes the 
exocrine pancreatic enzyme trypsinogen 1, is more abundant 
pretransplant than posttransplant (Figure 4, left), suggesting 
contaminating exocrine cells that are present pretransplant 
do not survive engraftment. In α cell populations, PRSS1, 
CTRB1, and CTRB2 (encoding chymotrypsinogen 1b and 
2b, respectively) are more abundant pretransplant than post-
transplant (Figure 4, right), again suggesting that exocrine 
cells do not survive following engraftment. For both β and 
α cells, hormone transcript levels are relatively higher in 
the posttransplantation sample. Coupled with the decline in 
transcripts for protease genes of the exocrine pancreas, these 
data suggest that engraftment under the kidney capsule fa-
vors survival of endocrine cells and their continued secretory 
function.
Given that we previously reported 10 genes whose expres-
sion is distinct to highly purified human β cells and another 
10 genes specific to highly purified α cells,12 we wished to 
determine which of these genes might be differentially ex-
pressed pre and posttransplant. All 10 of the β cell-specific 
genes are expressed in both pre and posttransplant cells, and 
three genes (INS, MAFA, and PDX1) are significantly more 
highly expressed post-engraftment (Table 2, left). Similarly, 
10 genes with distinctly high expression in α cells12 are de-
tected both pre and posttransplant, of which three are dif-
ferentially expressed (all increased) in the posttransplant 
samples (Table 2, right).
In addition, we find that thioredoxin interacting protein 
(TXNIP) is expressed at higher levels in both α and β cells 
post-engraftment (β  =  6.8 fold higher, P-adj  =  6  ×  10−31; 
α = 4.7 fold higher, 3 × 10−20 P-adj). TXNIP is a thioredox-
in-binding protein that regulates endoplasmic reticulum (ER) 
stress and is elevated by high blood glucose.19 Since TXNIP 
upregulation induces β-cell apoptosis, we examined gene ex-
pression in the apoptosis pathway. Virtually all of the apopto-
sis genes with differential expression pre and posttransplant 
are expressed at lower levels posttransplant; while INS ex-
pression is also increased in the posttransplant samples, no 
concomitant increase in the genes of the ER stress pathway is 
observed (data not shown). This could indicate that the graft 
F I G U R E  4  Transcript abundance pretransplant and posttransplant. The expected counts output from RNA-Seq by Expectation-Maximization 
(RSEM) for the 200 most abundant pretransplant transcripts (average of three human donors) are plotted on the x-axis and the corresponding values 
for posttransplant transcripts are plotted on the y-axis for β and α cells. Perfect correlation is indicated by the dotted line 
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environment is less stressful than standard ex vivo islet cul-
ture conditions.20-22
3.4 | Single-cell RNA-Seq reveals the 
expected islet cell populations within the 
recovered grafts
To further highlight the broad applicability of our islet 
graft recovery protocol, we performed single-cell RNA-
Seq (scRNA-Seq) on human islet grafts posttransplant. 
In this experiment, five NSG mice were transplanted with 
human islets from a nondiabetic donor (Donor 15071, see 
Table 1). At 3 weeks posttransplant, islet grafts were dis-
sociated, stained for islet hormones (excluding pancreatic 
polypeptide, made by γ cells), and the cells sorted into three 
384-well plates for scRNA-Seq. Using uniform manifold 
approximation and projection (UMAP)23 in tandem with 
our End Sequence Analysis Toolkit (ESAT)24 and after 
filtering for cells with total read counts below 10% of the 
plate average, we find that posttransplant islet grafts seg-
regate into five distinct groups of cells (Figure 5). Four of 
the major cell populations are identified by their hormone 
expression as β, α, δ, and γ cells; the fifth hormone-neg-
ative cell population was not further characterized. The 
identification of γ cells in our single-cell analysis validates 
the power of our graft recovery method to “capture” even 
minor populations of endocrine cells, as γ cells typically 
constitute only < 5% of the total human islet cells.25 Of 721 
cells identified as β, α, or δ by transcriptome and 710 cells 
identified as expressing INS, GCG, or SST by FACS, 665 
cells are identified as the same endocrine cell type by both 
hormone staining and unbiased clustering of transcriptome 
data. These three human islet cell populations correspond 
with our bulk hormone-specific data, as well as published 
reports of single-cell analyses of human islets isolated from 
organ donors (reviewed in 1). We did not detect subpopula-
tions within the β cells, likely a consequence of the small 
number of engrafted cells recovered and the effects of 
fixation and staining on those cells' mRNA. In the future, 
sorting cells without fixation, identifying endocrine cells 
using autofluorescence,26 and then capturing transcripts 
with SCRB-seq13,27 will enhance our single-cell analyses. 
Applying such approaches to islet cells both pre- and post-
engraftment will aide us in identifying islet cell subpopula-
tions reported by others.28,29
Together, these data suggest that human islets maintain 
and/or recover much of their expression “identity” follow-
ing in vivo engraftment in unmanipulated euglycemic mice. 
Therefore, human islets engrafted in mice are an excellent 
model for studying transcriptional changes in vivo following 
metabolic (e.g., hyperglycemia or high-fat diet) or pharmaco-
genetic challenges.
F I G U R E  5  Single-cell transcriptomes from posttransplant 
human islets. Engrafted human islets were recovered for scRNA-
Seq analysis; UMAP shows distinct subpopulations, including four 
hormone-specific cell subsets 
β gene Fold change P adj α gene Fold change P adj
INS 2.55 3.6 × 10−06 GCG 1.78 .0007
IAPP 4.33 .2 IRX1 1.71 .05
PDX1 2.09 .0003 IRX2 1.70 .007
MAFA 2.03 .0005 ARX 1.57 .05
NKX6-1 1.86 .0002 BAMBI 1.50 .3
PCSK1 2.02 .2 DPP4 2.18 1.3 × 10−05
KCNQ2 1.25 .5 PTPRT 2.29 2.1 × 10−06
GLIS3 1.27 .2 PTPRD 1.04 .9
ACVR1B 1.42 .05 POU6F2 2.84 4.2 × 10−08
CASR 1.65 .03 KCND3 .99 1
Note: Genes in bold have greater than 2-fold change and adjusted P values < .05.
T A B L E  2  Differential expression 
of α- and β-associated transcripts 
posttransplant
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3.5 | Viable cells are recovered from 
transplanted human embryonic stem cell-
derived β cells
Last, to show the feasibility of our graft recovery method for 
other experimental sources of β cells, an additional trans-
plant study was performed using human embryonic SC-β 
cells (see MATERIALS AND METHODS) to determine the 
ability of our methodology to capture their in vivo devel-
opment and function. At 14 days posttransplantation, grafts 
were recovered and the isolated SC-β cells were incubated 
with the live/dead stain 7-aminoactinomycin (7-AAD) 
(Figure 6A). For FACS, all viable (7-AAD-negative) cells 
were gated on the FITC channel, which detects the intrin-
sic autofluorescence found in β cells (Figure 6B). We re-
covered nearly 190  000 live autofluorescent cells, which 
we confirmed as INS positive by immunostaining (Figure 
6C). As a test for function, whole-cell calcium currents were 
measured in both the pretransplant and recovered graft cells, 
which stained with dithizone. Patch-clamp experiments with 
recovered SC-β cells reveal that calcium currents underlying 
calcium-dependent insulin exocytosis30-32 were robust and 
similar to currents observed in human primary islets in that 
they were sensitive to the L-type calcium channel agonist 
FPL 64176 (Figure 6D).
4 |  DISCUSSION
In this study, we present the first report of a methodology 
to recover sufficient numbers of viable cells from long-term 
human pancreatic islet transplants to allow single-cell and/
or bulk hormone-specific examination of transcriptome and 
functional analyses posttransplant. Whereas earlier reports 
of RNA analyses from bulk-dissected islet grafts were ham-
pered by the inability to distinguish which islet cell subset 
contributed to gene expression, a critical advantage of our 
protocol is that it allows FACS-based identification of spe-
cific islet cells including α, β, δ, γ, and hormone-negative 
cells. Moreover, because our protocol allows recovery of 
viable cells, we were able to perform functional posttrans-
plantation in vitro analyses, an essential aspect of islet graft 
interrogation. These data can be compared to islet graft phys-
iology in vivo and circulating INS levels following glucose 
challenge. Importantly, our study also reveals the fidelity of 
engrafted human islets recovered from experimentally unma-
nipulated mice to recapitulate the hormone-specific pheno-
type and gene expression of the original primary donor islets, 
as well as the human-specific frequencies of heterotypic con-
tacts. The slight upward trend in α-cell transcription observed 
posttransplant may well reflect the slightly increased purity 
of the sorted posttransplant cells that results from the death of 
F I G U R E  6  Assessment of SC-β cells recovered from grafts. A, Engrafted SC-β cells were assessed for viability with 7-AAD. B, Viable 
cells were measured for intrinsic autofluorescence (FITC) found in β cells. C, Live autofluorescent cells were confirmed as INS positive by 
immunostaining. D, Patch-clamp recordings of SC-β cells show robust calcium currents (a feature of calcium-dependent insulin exocytosis) and 
sensitivity to the L-type calcium channel agonist FPL 64176 
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contaminating acinar tissue following engraftment. Indeed, 
we identify a similar uptick in β-cell gene transcription post-
transplant, with a significant increase in INS and its transcrip-
tional activators PDX1 (pancreatic and duodenal homeobox 
1) and MAFA (a member of the Maf family of transcription 
factors).
Although INS and TXNIP are upregulated, we observe no 
changes in the ER stress pathways that would suggest that 
this minor uptick in INS transcription results in a sufficient 
increase in INS protein production to overload the ER and 
trigger the unfolded protein response. In addition, the vast 
majority of gene expression changes in the apoptotic path-
way genes are decreased post-engraftment. This is key to 
interpreting any data from recovered human islets in which 
the engrafted mice have been subjected to experimental ma-
nipulation, and suggests that changes in gene expression or 
function that may occur in transplanted islets would be due 
to the in vivo effects on the experimental treatment, rather 
than effects from the transplant and engraftment process it-
self. Moreover in future experiments, analysis of increased 
numbers of islet cells from both pre and posttransplant con-
ditions should reveal whether subpopulations within the five 
identified cell types can be detected and whether any changes 
within subgroups occur with transplantation and/or experi-
mental treatment.
Accordingly, our current protocol allows for quantitative 
molecular analyses of specific endocrine subtypes of human 
islet cells during controlled experimental conditions in vivo, 
such as when engrafted mice are exposed to a high-fat diet, 
infected with viruses, or exposed to inflammatory cytokines; 
similarly, it can be used to interrogate the effects of poten-
tial therapeutics on pancreatic islets from diabetic donors. In 
addition, investigation of hormone-negative populations will 
enable characterization of novel cell types and their signaling 
molecules that may affect islet function in vivo, such as the 
report that islet-associated pericytes improve islet survival, 
proliferation, and function.33 Finally, this methodology also 
permits in vivo investigation of human SC-β cell develop-
ment, a necessary step in the optimization of this process and 
development of methodologies for personalized treatment of 
diabetes.34
In summary, studies of engrafted human islets may pro-
vide critical assessment of functional effects of in vivo ma-
nipulation of human islets that have been previously lacking. 
Such methodology should provide answers to fundamental 
questions in the field concerning dedifferentiation, compen-
sation, and islet gene expression, and reveal how human islet 
cell populations adapt and compensate in vivo under stress 
conditions, and how they respond to treatment with potential 
diabetes therapies. We have shown that our islet graft recov-
ery method, though technically challenging, yields sufficient 
numbers of cells suitable for single-cell and/or bulk hor-
mone-specific RNA-Seq analysis. Importantly, we are able 
to recover functional β cells from grafts. Such approaches 
will facilitate a more complete understanding of how indi-
vidual human islet cells respond during various physiologic 
or pathologic conditions and will lead to better strategies for 
studying human islets in the context of the whole system to 
improve overall islet function and cell survival in diabetic or 
at-risk individuals.
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